MFDS — authorised 5 September 2014
- Marketing authorisation holder: KERYX BIOPHARMS
- Status: likely_approved
🇰🇷 Auryxia in South Korea
MFDS authorised Auryxia on 5 September 2014
Marketing authorisation
Auryxia in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Hematology approved in South Korea
Frequently asked questions
Is Auryxia approved in South Korea?
Yes. MFDS authorised it on 5 September 2014.
Who is the marketing authorisation holder for Auryxia in South Korea?
KERYX BIOPHARMS holds the South Korean marketing authorisation.